Fondaparinux Sodium Injection
Product Images NDC 55111-680

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 55111-680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg2scarton (10mg2scarton)

This is a description of a medication contained in a single-dose syringe. The syringe contains 10mg of fondaparinux sodium, USP, which is injected subcutaneously. The solution is isotonic and may contain pH adjusters. It is recommended to consult the package insert for dosage instructions. The syringe is affixed with an active needle protection system and contains two doses. The medication should be stored at a controlled room temperature and any unused portion should be discarded. The GTIN (bar code) for the medication is 0355111681028.*

FDA Label Image

25mg2scarton (25mg2scarton)

This is a description of a medication called Fondaparinux Sodium Injection. The medication comes in the form of a single-dose, prefilled syringe with 2.5 mg/0.5 mL. The solution contains fondaparinux sodium and an isotonic solution of sodium chloride and water for injection. The recommended dose is 2.5 mg for subcutaneous injection once a day. The medication should be stored at room temperature. The label on the package should be affixed to the medication.*

FDA Label Image

5mg2scarton (5mg2scarton)

This appears to be a description of a pharmaceutical product called "Fondapal", which is a single-dose prefilled syringe containing 5 mg of a compound called "fondaparna sodiun". The recommended dose is one injection subcutaneously per day. The product should be stored at a controlled room temperature and any unused portions should be discarded. There are also details about the product packaging and identification numbers.*

FDA Label Image

75mg2scarton (75mg2scarton)

This text appears to be a description of an injection drug called "Fondaparinux Sodium Injection" that comes in pre-filled syringes containing 7.5 mg/0.6 mL of the drug. The recommended dose is 0.5 mg subcutaneous injection, once daily, and it should be stored at 20-25°C (68-77°F). The injection also contains sodium chloride and water for injection and may contain pH adjusters like sodium hydroxide and/or hydrochloric acid. There are two single-dose pre-filled syringes in each container.*

FDA Label Image

Fig (Fig1)

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

FDA Label Image

Fig4 (Fig4)

FDA Label Image

Fig5 (Fig5)

FDA Label Image

Instrucn2cond (Instruc2cond)

This is a set of instructions for disposing of used syringes and needles containing fondaparinux sodium through a FDA-clared sharps disposal container made of a heavy-duty puncture-resistant plastic that can be sealed tightly to prevent leaks and kept stable during disposal. It is recommended to follow community guidelines for safe disposal, and for more information, consult the FDA website. It is not advised to dispose of sharps in household trash or recycling.*

FDA Label Image

Instructions1 (Instructions1)

FDA Label Image

Instructions2 (Instructions2)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.